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Routine Surveillance in Vascular Access for Hemodialysis
Mitchell L. Henry*
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There is increasing evidence that surveillance of AV access for haemodialysis prevents access thrombosis and improves the
quality of care. This article reviews the evidence for surveillance and the various strategies and techniques available for
detection of the failing access.
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The two basic components of a vascular access for
hemodialysis that allow for its routine, uninterrupted
use and to provide for optimal dialysis efficiency are
high flow and durability. A functioning access is very
important to the patient, dialysis center, and payors. Ac-
cess dysfunction that increases intra-access pressures
and decreases flow can lead to thrombosis of the fistula
or graft. Thrombosis requires additional measures to re-
store patency, which are costly and time consuming and
usually requires the introduction of a temporary central
venous dialysis catheter, which has its ownunique com-
plications. These all lead to significantly reduced quality
of life for patients with end-stage renal disease (ESRD).1
Dysfunctioning but patent grafts or fistulas may also
lead to extendeddialysis treatment times and/or under-
dialysis. A recent study demonstrated that even seem-
ingly minor decreases in the dialysis prescription led
to significantly increased morbidity, increased hospital-
ization, length of stay and costs.2
This argues the need for structured, routinemethods
to identify access dysfunction prior to thrombosis. Pro-
spectivemonitoring ofAVfistulae andgraftsmayallow
for earlier detection of anatomic lesions, which may
then be corrected by an appropriate intervention.
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monitor access function including physical examina-
tion, direct and indirect flow measurements, intra-
access resistance, intra-access pressure and access
recirculation. As a result of the innate differences
between AV fistulas and grafts, these tests may be
more useful in one than the other (e.g. urea recircula-
tion may be more applicable for autogenous fistulas).
Several assumptions need to be made when consid-
ering dialysis access surveillance. First, and most im-
portantly, these studies need to be done routinely and
serially. There have been many suggestions as to the
appropriate timing, but the optimal interval is proba-
bly monthly.3 Secondly, the recorded observations
must be readily available for future use in order to
follow trends over time. Intervention should not be
performed as a result of a single abnormal test, but se-
rial measurements should be used to identify trends
indicating deterioration of flow or increasing resis-
tance over time. Triggers then need to be placed
such that at a point in time the abnormalities are ad-
dressed by appropriate diagnostic testing and cor-
rective intervention. It is also becoming clear that
following intervention, functional testing of the access
should be performed to verify that the intended im-
provement in access flow and decrease in access resis-
tance has been achieved.
Flow Measurements
Direct and indirect flow measurements are common
surveillance tools. Direct flow measurements can
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resonance angiography (MRA) and used serially to
detect those accesses at risk for dysfunction and
thrombosis. Their routine use is limited by the need
for expensive equipment so that their overall cost is
high and unlikely to be offset by reimbursement. In
addition, duplex ultrasound accuracy and reproduc-
ibility are very operator dependent. However, such
studies provide a unique opportunity not only to
measure flow, but also to delineate stenoses
accurately.
Indirect flow can be quantified using in-line tech-
niques at the time of dialysis, after needle placement.
Several methods exist including the use of indicator
dilution techniques such as ultrasound dilution,4
transcutaneous access flow rate,5 glucose dilution,6
timed ultrafiltration,7 ionic dialysis8 and differential
conductivity.9
Ultrasound dilution techniques are currently the
most commonly used: Ultrasound probes are placed
on the dialysis lines and they are then reversed, creat-
ing recirculation. A saline bolus is injected into the
venous line. The venous probe samples the concentra-
tion of the injected bolus, the arterial sensor measures
the concentration of the bolus following dilution
through the vascular access, and the classical indica-
tor dilution equation is applied, resulting in a flow
calculation of the access.
Pressure Measurements
Dynamic venous pressures (determined while the
pump head is turning) are difficult to standardize,
which limits their usefulness, whereas static venous
pressures (routinely measured during each dialysis
session prior to starting the dialysis pump) are sim-
ple and more frequently used. Normally, systemic
pressure rapidly dissipates over the length of an
AV graft or fistula. The presence of a stenosis within
the inflow, the outflow or the access itself will alter
this gradient so that changes in pressure at the arte-
rial and venous ends of the access can be used for its
detection. The ratio of intra-access pressure at the ar-
terial end to mean arterial pressure (MAP) and the
ratio of intraaccess pressure at the venous end to
MAP can be calculated. With normal venous outflow,
the venous/MAP ratio should be low, whereas with
increasing stenosis, this ratio (along with the arterial
ratio) will increase. A midgraft stenosis would cause
an increasing pressure in the arterial side of the con-
duit while the venous ratio would remain low. In
contrast, both ratios would be low in the presence
of an arterial inflow stenosis. As always, singleEur J Vasc Endovasc Surg Vol 32, November 2006readings should not influence decision-making,
rather the data should be examined serially for
changes or trends over time.
Physical Examination
Physical examination is an important yet often forgot-
ten factor in following graft function over time. All
members of the vascular access team, including phy-
sicians, nurses, technicians and patients themselves
should be proficient at assessing vascular access. No
special equipment or testing is required, which makes
it one of the more attractive methods for monitoring
graft function. Evidence of venous stenosis may in-
clude prominent collateral veins, edema, changes in
the characteristics of the thrill/pulse, and prolonged
bleeding from needle sites.10
Recirculation
Recirculation occurs when dialyzed blood travels back
to the dialyzer without adequate mixing with the
systemic circuit. This can be caused by a stenosis of
the access outflow. Recirculation can be accurately
and reproducibly measured by using ultrasound dilu-
tion or differential conductivity techniques. Calculated
urea recirculation has also been used historically to
identify graft outflow stenosis. However, urea recircu-
lation is relatively insensitive and only renders a posi-
tive result at very low access flows. It is therefore not
recommended for AV grafts, which require high flows
to maintain patency. In contrast, it is a reasonable test
in patients with native fistulas, which can remain pat-
ent at low flows.
Discussion
The basic assumption of access surveillance is that
grafts and fistulas with high flow and low outflow
resistance remain patent. With increasing venous
outflow resistance, measured flows decrease and mea-
sured resistance increases. Intraaccess pressure ratios
(both arterial and venous) also will rise in the setting
of venous stenosis. Older studies report that 90% of
graft thromboses occur as a result of venous outflow
abnormalities.11 This anatomic abnormality will be
reflected in both flow decreases and resistance
increases. Newer observations12 suggest that arterial
inflow abnormalities may be the cause of access
dysfunction or thrombosis in a significantly higher
percentage of cases than previously thought. While
flows will decrease with arterial stenosis, resistance
measurements may not be perturbed, leading to
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access monitoring.
A surveillance program must first identify the
baseline measurement of choice, and then follow it se-
rially to identify trends over time. A graft will reach
its baseline flow early following creation, whilst a fis-
tula may take months to reach its baseline flow. Rou-
tine studies, probably monthly, need to be measured,
recorded, and analyzed.
Many studies13e16 show that routine measure-
ments can detect the access at risk for thrombosis,
and allow for definitive study and treatment of the an-
atomic abnormality. There are no large randomized
prospective studies that show definitive increases in
the life span of a particular access with the use of sur-
veillance. Some authors17e19 have argued that these
techniques do not prolong prosthetic graft survival
and may actually increase the costs of access mainte-
nance as a result of the greater number of corrective
procedures (primarily percutaneous transluminal
angioplasty-PTA) performed. However, avoiding ac-
cess thrombosis alone is beneficial as it requires ur-
gent therapy (interventional or surgical), results in
the loss of the optimal dialysis efficiency, requires
the need for a temporary catheter (with a risk of fur-
ther complications) and significantly increases costs.
Importantly, access thrombosis is one of the dialysis
patient’s greatest worries.20
For prosthetic vascular access grafts, older studies
have shown that relative flow rates can predict the
propensity for thrombosis.21,22 The higher the flow,
the less likely the graft is prone to thrombosis. Grafts
with flows greater than 800ml/minute have a risk of
thrombosis that is significantly less than those under
800ml/minute. Studies that have looked at decreasing
flow as a trend have shown an increasing probability
of demonstrating anatomic lesions and subsequent
thrombosis.6,23,24 Besarab14 and others15,25e27 have
championed the use of venous pressures and intraac-
cess pressure monitoring, demonstrating that higher
venous pressures and intraaccess pressures lead to
an increased rate of access thrombosis. Those using
newer techniques, such as ultrasound dilution, have
also reinforced the concept of flow monitoring as an
effective technique to measure access flow and predict
impending thrombosis.28
Because patency in AV fistulas can be maintained
with significantly lower flows than in AV grafts,
they require a different approach to surveillance. AV
fistulas dissipate pressure downstream rapidly as a
result of the many collateral outflow pathways. There-
fore, intraaccess pressure ratios will be significantly
less than a graft, and the use of these measurements
may not be as valuable as with a prosthetic access.The number of collateral veins in an AV fistula also
render dynamic and static venous pressure monitor-
ing less predictive of thrombosis.
It is therefore more important to consider relative
changeswith serialmeasurements over timewith these
accesses. Nevertheless, there is solid evidence29,30 to
support preemptive interventional/surgical proce-
dures to improve longitudinal survival in AV fistulas.
Recirculation studies (e.g. urea recirculation) may be
valuable in the AV fistula. It is the author’s opinion
that serial physical examinations in patients with AV
fistulas can provide particularly important additional
information.
When routine surveillance identifies the access at
risk for thrombosis, the next step is to proceed to an-
giography for a definitive diagnosis and PTA or surgi-
cal repair. Duplex ultrasound has been advocated by
some31 as an interim step, prior to angiography, as it
may be as valuable for grading the stenosis as well
as quantifying the current flow. There is an emerging
concept that once an intervention has been performed,
anatomic confirmation is not adequate and additional
studies (e.g. duplex ultrasound) should be used to
demonstrate a physiologic improvement in flow.31,32
Summary
 Hemodialysis access has a high rate of
dysfunction.
 Access thrombosis contributes to significant prob-
lems for clinicians, dialysis personnel, patients
and payors.
 Access surveillance can identify those that
develop anatomic abnormalities that place them
at risk for thrombosis.
 There are many tools to use for surveillance mon-
itoring at the disposal of carers. Dialysis units
should choose the tool that best meets their needs
and abilities, and to use it to produce serial
measurements.
 Data should be carefully recorded, readily avail-
able and periodically analyzed to detect undesir-
able trends.
 Once trigger points are met, accesses should be
definitively studied using duplex scanning and/
or fistulography and appropriate revision per-
formed by angioplasty or surgery.
 After correction of the problem, new baseline
values should be obtained and surveillance once
again instituted.
 Rigid application of these concepts will allow
us to better care for our patients requiring
hemodialysis.Eur J Vasc Endovasc Surg Vol 32, November 2006
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